These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21609522)

  • 1. [Evaluation on the neointimal coverage post drug-eluting stent implantation by optical coherence tomography].
    Tian F; Chen YD; Chen L; Sun ZJ; Liu HB; Liu CF; Guo J; Wang JD
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):204-7. PubMed ID: 21609522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of very early neointimal coverage post drug-eluting stent implantation using optical coherence tomography].
    Wang TJ; Yang YJ; Xu B; Xu L; Sun ZW; Ma C; Tang Y; Tian Y; Yuan WM; Chu Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Sep; 40(9):747-51. PubMed ID: 23141086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Visualization of intimal proliferation of drug-eluting stent and bare mental stent by use of optical coherence tomography].
    Chen BX; Ma FY; Luo W; Xie WL; Sun SH; Guo XM; Wang F; Zhao XZ; Chu XW
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1102-6. PubMed ID: 16796834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of optical coherence tomography in the evaluation of neointimal coverage after stent implantation.
    Murata A; Wallace-Bradley D; Tellez A; Alviar C; Aboodi M; Sheehy A; Coleman L; Perkins L; Nakazawa G; Mintz G; Kaluza GL; Virmani R; Granada JF
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):76-84. PubMed ID: 20129535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of neointimal coverage and apposition with various drug-eluting stents over 12 months after implantation by optical coherence tomography.
    Li S; Wang Y; Gai L; Yang T; Liu H; Wang Z; Bai Q; Xu X; Chen Y
    Int J Cardiol; 2013 Jan; 162(3):166-71. PubMed ID: 21641053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neointimal coverage on drug-eluting stent struts crossing side-branch vessels using optical coherence tomography.
    Her AY; Lee BK; Shim JM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Am J Cardiol; 2010 Jun; 105(11):1565-9. PubMed ID: 20494663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
    Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherence tomographic analysis of in-stent neoatherosclerosis after drug-eluting stent implantation.
    Kang SJ; Mintz GS; Akasaka T; Park DW; Lee JY; Kim WJ; Lee SW; Kim YH; Whan Lee C; Park SW; Park SJ
    Circulation; 2011 Jun; 123(25):2954-63. PubMed ID: 21646494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.
    Kim JS; Hong MK; Shin DH; Kim BK; Ko YG; Choi D; Jang Y
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1147-55. PubMed ID: 23153915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents.
    Moore P; Barlis P; Spiro J; Ghimire G; Roughton M; Di Mario C; Wallis W; Ilsley C; Mitchell A; Mason M; Kharbanda R; Vincent P; Sherwin S; Dalby M
    JACC Cardiovasc Interv; 2009 May; 2(5):437-44. PubMed ID: 19463468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-week interval optical coherence tomography: imaging evidence on neointimal coverage completion after implantation of the Endeavor zotarolimus-eluting stent.
    Nishinari M; Shimohama T; Tojo T; Shiono T; Shinagawa H; Kameda R; Aoyama N; Izumi T
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E871-8. PubMed ID: 23873677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound.
    Kitabata H; Loh JP; Pendyala LK; Omar A; Ota H; Minha S; Magalhaes MA; Torguson R; Chen F; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2014 Apr; 15(3):149-55. PubMed ID: 24767313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of neointimal coverage of overlapping sirolimus-eluting stents by optical coherence tomography.
    Tian F; Chen YD; Sun ZJ; Chen L; Yuan F; Song XT; Lü SZ
    Chin Med J (Engl); 2009 Mar; 122(6):670-4. PubMed ID: 19323932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neointimal coverage of sirolimus-eluting stents 6 months and 12 months after implantation: evaluation by optical coherence tomography.
    Yao ZH; Matsubara T; Inada T; Suzuki Y; Suzuki T
    Chin Med J (Engl); 2008 Mar; 121(6):503-7. PubMed ID: 18364133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different patterns of vascular response between patients with or without diabetes mellitus after drug-eluting stent implantation: optical coherence tomographic analysis.
    Tanaka N; Terashima M; Rathore S; Itoh T; Habara M; Nasu K; Kimura M; Itoh T; Kinoshita Y; Ehara M; Tsuchikane E; Asakura K; Asakura Y; Katoh O; Suzuki T
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1074-9. PubMed ID: 20965467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
    Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of neointimal coverage by optical coherence tomography of a sirolimus-eluting stent versus a bare-metal stent three months after implantation.
    Xie Y; Takano M; Murakami D; Yamamoto M; Okamatsu K; Inami S; Seimiya K; Ohba T; Seino Y; Mizuno K
    Am J Cardiol; 2008 Jul; 102(1):27-31. PubMed ID: 18572031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.